There is no condition information for this clinic
Assessment and management of patients with cervical screening abnormalities or symptoms of cervical disease.
North South North West Statewide
The National Cervical Screening Program dictates circumstances where colposcopic examination is required.
All patients with screen detected abnormalities (according to protocol), those with intrauterine exposure to diethylstilbestrol, and those where physical examination reveals concern.
All symptomatic patients should be referred to colposcopy where they will be triaged according to strict criteria and be seen in an appropriate clinic.
A referral (preferably faxed) is required for all new appointments and must conform with the Referral Standards and specifically include:
- a description of symptoms and signs
- CST result Co-Test results
- swab results, previous pathology
- relevant medical history
- relevant past treatments
- current medication
Clinic Appointments – Appointments are based on clinical priority:
Proceed to Emergency Department (ED). Please contact ED Medical Officer in Charge:
LGH ED – Phone: (03) 6777 6405 Fax: (03) 6348 7382
MCH ED – Phone: (03) 6478 5120 Fax: (03) 6426 5115
NWRH ED – Phone: (03) 6493 6340 Fax: (03) 6430 6691
RHH ED - Phone: (03) 6166 6100 Fax: (03) 6222 8919
Urgent / category 1
Urgent referrals should be accompanied by a phone call to the Consultant/Registrar to organise urgent review and the referral must be faxed.
We will endeavour to see these patients within four weeks, or sooner if clinically indicated.
Routine / category 3
In Turn (next available)
Will be seen within 12 weeks
For use by health professionals only
Pathways for the management of cervical screening abnormalities are found through the following websites: